Cost-Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand. Suphachai Chirakup1,2 Nathorn Chaiyakunapruk1,3,4 Usa Chaikledkeaw5,6 Petcharat Pongcharoensuk5 Boonsong Ongphiphadhanakul7 Stephane Roze8 William J. Val

Sripen Tantivess & Viroj Tangcharoensathien Abstract Thailand achieves universal health coverage through the introduction of 3 benefit schemes: the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme, and Universal Coverage Scheme. The primary benefit package of these sche

There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car

There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car

About one in six children and teenagers are also obese, according to the Journal of the American Medical Association report which showed that obesity remains a significant problem in US society despite efforts to combat it.“Obesity prevalence shows little change over the past 12 years, although the

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. AMR occurs when antimicrobials, such as antibiotics, become ineffective against the microorganisms that cause disease. This ineffectiveness can lead to serious infections, increased mortality, and significant economic losses.The Global Antibiotic Policy I

Infectious disease models can be used to forecast future outbreaks and estimate the impact of interventions to support policy. Although infectious disease modelling is a well-established method, it has recently gained prominence during the COVID-19 pandemic as an important tool to support deci

K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand

Abstract The cost of screening interventions for road-accident prevention Chutima Kumdee*, Kuntika Dumrongprat*, Pritaporn Kingkaew*, Yot Teerawattananon*      *Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health Although the burden on mortality, morbid

วันที่ 16 มิถุนายน 2559 ดร.นพ.ยศ ตีระวัฒนานนท์ หัวหน้าโครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ หรือ HITAP พร้อมด้วยทีมนักวิจัย HITAP เข้าร่วมประชุมผู้มีส่วนได้ส่วนเสียเพื่อนำเสนอผลการศึกษาเบื้องต้นของการทบทวนวรรณกรรมเกี่ยวกับเทคโนโลยีทางการแพทย์ที่มีค่าใช้จ่ายสูงในระบบประกันสุขภาพของเวียดนาม จัดโด